✦ LIBER ✦

Mo1325 Cost-Effectiveness of Infliximab Scheduled Maintenance Treatment for the Management of Patients With Moderate-to-Severe Ulcerative Colitis

✍ Scribed by Monfared, Amir A. Tahami; Feagan, Brian G.

Book ID: 122139058
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 227 KB
Volume: 144
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(13)62358-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A model of the long-term cost effectiven

A model of the long-term cost effectiveness of scheduled maintenance treatment with infliximab for moderate-to-severe ulcerative colitis

✍ H. H. TSAI; Y. S. PUNEKAR; J. MORRIS; P. FORTUN 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 471 KB

Sa1108 Cost-Effectiveness of Golimumab V

Sa1108 Cost-Effectiveness of Golimumab Versus Infliximab and Adalimumab for the Treatment of Moderate to Severe Ulcerative Colitis

✍ Thorlund, Kristian; Druyts, Eric; Kanters, Steve; Eapen, Shawn; Mills, Edward 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 235 KB

Cost-Effectiveness Of Infliximab Versus

Cost-Effectiveness Of Infliximab Versus Colectomy For The Treatment Of Severe Active Ulcerative Colitis In Poland

✍ Goszczyńska, K.; Wrona, W.; Niewada, M.; Black, C.M.; Fan, T.; Lobodzinski, P. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

Infliximab, Azathioprine, or Infliximab

Infliximab, Azathioprine, or Infliximab + Azathioprine for Treatment of Moderate to Severe Ulcerative Colitis: The UC Success Trial

✍ Remo Panccione; Subrata Ghosh; Stephen Middleton; Juan R. Marquez; Igor Khalif; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 389 KB

Exogenous alkaline phosphatase for the t

Exogenous alkaline phosphatase for the treatment of patients with moderate to severe ulcerative colitis

✍ Milan Lukas; Pavel Drastich; Michal Konecny; Paolo Gionchetti; Ondrej Urban; Fra 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

Background: Increased activity of intestinal alkaline phosphatase (AP) occurs locally in patients with ulcerative colitis (UC), aimed at repairing inflammatory tissue damage. We evaluated the safety and preliminary efficacy of exogenous AP administered to patients with UC in an open-label, first-in-

786 The Pharmacokinetics of Infliximab I

786 The Pharmacokinetics of Infliximab Induction Therapy in Patients With Moderate to Severe Ulcerative Colitis

✍ Brandse, Johannan F.; van der Kleij, Desiree; Wolbink, Gert-Jan; Rigter, Irma M. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 135 KB